investor harm

Class action lawsuit filed against $ENPH alleging overstatement of inventory management and tax credit mitigation capabilities, covering April-October 2025 purchases.

Class action filed against Navan ($NAVN) alleging IPO prospectus misled investors on sales and marketing expense requirements. Claim period deadline: April 24, 2026.

Class action filed against $EOSE alleging materially false statements and non-disclosure of production delays, battery downtime, and quality control failures.

Bronstein, Gewirtz & Grossman files class action against BellRing Brands alleging false sales statements tied to inventory buildup rather than genuine demand.

Class action lawsuit filed against $PLUG alleging false statements on DOE funding and hydrogen facilities between January-November 2025. Investors have until April 3, 2026 to seek lead plaintiff status.

Class action lawsuit filed against Ultragenyx Pharmaceutical alleging false statements about setrusumab efficacy for Osteogenesis Imperfecta treatment based on flawed trial comparisons.

Class action lawsuit filed against AMC Entertainment over alleged securities violations related to APE preferred equity units. Investors claim material misstatements about distribution rights.

Alight Inc. faces class action lawsuit alleging executives misled investors about CEO leadership, capital returns, and financial targets from November 2024 to February 2026.

Class action lawsuit filed against Eos Energy Enterprises ($EOSE) alleging executives made false statements about production capacity, battery downtime, and quality issues from November 2025 to February 2026.

Class action filed against $TCOM alleging false statements about regulatory risks from monopolistic practices. Lead plaintiff deadline set for May 11, 2026.

Class action lawsuit filed against monday.com alleging securities fraud over false revenue statements and concealed growth deceleration during September 2025-February 2026 period.

Class action lawsuit filed against Ramaco Resources ($METC) alleging executives made false statements about Brook Mine development progress, covering July-October 2025 investors.

Class action lawsuit filed against Nektar Therapeutics alleging executives made false statements about REZOLVE-AA trial enrollment, claiming protocol violations negatively impacted results.

Class action lawsuit filed against $CORP alleging false statements about relacorilant clinical trial strength and FDA approval prospects. Investors from Oct 2024-Dec 2025 urged to participate.

Class action lawsuit filed against Driven Brands Holdings alleging securities fraud, false financial statements, and weak internal controls between May 2023 and February 2026.

Bronstein, Gewirtz & Grossman LLC filed class action against Gemini Space Station ($GEMI) alleging materially false IPO statements regarding crypto platform viability and international expansion.

Class action lawsuit filed against $UQRR alleging materially false statements about FDA approval and BLA timeline delays. Investors urged to join by April 13, 2026 deadline.

Class action lawsuit filed against $PYPL alleging executives made false statements about revenue projections and 2027 targets under CEO James Chriss.

Class action filed against PomDoctor ($POM) alleging stock fraud through false statements, social media misinformation, and coordinated insider share dumping.

Class action filed against Picard Medical ($PMI) for alleged securities fraud involving false promotions, insider share dumping, and omitted risk disclosures. Lead plaintiff deadline April 3, 2026.